BioWorld MedTech

July 30, 2015

View Archived Issues

Drugs, Devices and More: The Foresite saga: Third capital fund gets $450M to carry strategy onward

Spectranetics enrolls study: Insider stock buys, enrollment give Spectranetics shares a modest bounce

Inside the Beltway: App association chief says fix health IT payment or face economic disaster

Financings: Bigfoot Biomedical raises $3.8 million

Agreements/contracts: Biodesix partners with Biognosys for HRM tech

Patent Watch: Luxcath awarded U.S. patent for tech visualizing ablated tissue

Products

Briefly noted

MDD's Orthopedics Extra

Edwards beats quarterly estimates: TAVR market growth propels Edwards'Q2 sales above analyst expectations

A booming transcatheter aortic valve replacement/implant market knocked quarterly sales out of the park for Edwards Lifesciences (NYSE: EW) (Irvine, Calif.). Read More

Latin America: A battle lost, but war continues in PIP case against T V Rheinland

Today's news in brief

BioWorld

IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa

BioWorld Science

Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...

TL1A is overexpressed in hidradenitis suppurativa

BioWorld Science

Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...

Illustration of head with maze that is missing parts

Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke

BioWorld Science

Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...

VST Bio’s VB-001 is neuroprotector after stroke

BioWorld Science

At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...